PRUCALOPRIDE MEDSURGE prucalopride (as succinate) 2 mg tablet blister pack

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

prucalopride succinate, Quantity: 2.642 mg (Equivalent: prucalopride, Qty 2 mg)

Beschikbaar vanaf:

Medsurge Pharma Pty Ltd

farmaceutische vorm:

Tablet

Samenstelling:

Excipient Ingredients: microcrystalline cellulose; titanium dioxide; macrogol 400; colloidal anhydrous silica; lactose monohydrate; iron oxide red; hypromellose; magnesium stearate; polysorbate 80

Toedieningsweg:

Oral

Eenheden in pakket:

28 tablets

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

Prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief.,? Before Prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation.,? If treatment with Prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

Product samenvatting:

Visual Identification: Pink, circular, film coated tablet with 'C' debossed on one side and '12' on the other side.; Container Type: Blister Pack; Container Material: PVC/PE/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorisatie-status:

Registered

Autorisatie datum:

2022-02-04